Nuvectis Pharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $2.4M | $6.7M | $5.7M |
| FY2022 | $6.2M | $20.4M | $20.0M |
| FY2023 | $7.0M | $19.2M | $19.1M |
| FY2024 | $8.9M | $18.6M | $18.5M |
| FY2025 | $13.3M | $31.7M | $31.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $2.4M | $6.7M | $5.7M |
| FY2022 | $6.2M | $20.4M | $20.0M |
| FY2023 | $7.0M | $19.2M | $19.1M |
| FY2024 | $8.9M | $18.6M | $18.5M |
| FY2025 | $13.3M | $31.7M | $31.6M |